Tezepelumab for refractory eosinophilic granulomatosis with polyangiitis-related asthma
Abstract Conventional immunosuppressants are ineffective for the management of EGPA-related asthma. Tezepelumab is a human monoclonal antibody that inhibits thymic stromal lymphopoietin (TLSP) that has proven efficacy in several phase 3 studies for the treatment of asthma. We treated with off-label...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMC
2024-07-01
|
| Seri Bilgileri: | Respiratory Research |
| Konular: | |
| Online Erişim: | https://doi.org/10.1186/s12931-024-02888-x |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|